Heritage Wealth Management (Arizona)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$219K Buy
2,640
+1,320
+100% +$107K 0.03% 322
2022
Q3
$105K Hold
1,320
0.03% 319
2022
Q2
$98K Hold
1,320
0.03% 337
2022
Q1
$119K Buy
+1,320
New +$122K 0.03% 348
2021
Q3
$166K Hold
1,320
0.06% 246
2021
Q2
$179K Buy
+1,320
New +$174K 0.07% 246

Other funds holding XBI

Heritage Wealth Management (Arizona)'s XBI Position: Q4 2022 in Review

Heritage Wealth Management (Arizona) increased its State Street SPDR S&P Biotech ETF (XBI) stake by 100% in Q4 2022, buying an estimated $107K and bringing the position to 2,640 shares worth $219K. The position accounts for 0.03% of the portfolio, ranked #322.

Heritage Wealth Management (Arizona) first reported a position in XBI in Q2 2021 and has held it in 6 quarters since. 746 funds tracked by Wall St. Rank hold XBI as of Q4 2022.

  • Heritage Wealth Management (Arizona) held 2,640 shares of State Street SPDR S&P Biotech ETF worth $219K as of Q4 2022.
  • Heritage Wealth Management (Arizona) bought 1,320 State Street SPDR S&P Biotech ETF shares in Q4 2022, an estimated $107K.
  • State Street SPDR S&P Biotech ETF made up 0.03% of Heritage Wealth Management (Arizona)'s portfolio in Q4 2022, its #322 holding.
  • Heritage Wealth Management (Arizona) first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and has held it in 6 quarters since.
  • 746 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2022.

Based on Heritage Wealth Management (Arizona)'s 13F filing for Q4 2022, filed 13 Feb 2023.